home *** CD-ROM | disk | FTP | other *** search
- BUSINESS, Page 63Business NotesPHARMACEUTICALSThalidomide's Second Chance
-
-
-
- Can a drug that once shattered thousands of lives now offer
- hope to thousands of others? Pregnant women in the 1950s took
- thalidomide to combat morning sickness. When some 12,000 gave
- birth to tragically deformed children, the doomed drug was
- abruptly withdrawn. Now it is making a quiet comeback. Andrulis
- Pharmaceuticals of Beltsville, Md., and Pediatric
- Pharmaceuticals of Westfield, N.J., have asked the Food and Drug
- Administration to approve thalidomide for experimental use.
- Andrulis wants it for a clinical study of patients with
- bone-marrow transplants. By suppressing the immune response,
- thalidomide may prevent the new marrow from attacking the body.
- Pediatric plans to provide the drug to investigators of lupus
- and AIDS-related mouth ulcers, which thalidomide could curtail.
- These small firms may have the field to themselves -- giant
- drugmakers are still unlikely to embrace a medicine with such
- a grim reputation.
-
-
-
-
-
-
-
-
-